SCOTUS rules native genes unpatentable: Implications for crop biotech

A gathering storm has been brewing in one area of the biotech arena for several years. The eye of the storm contains a pair of naturally-occurring human genes, BRCA1 and BRCA 2, which have implications for breast cancer diagnostics. With its ruling in Association for Molecular Pathology v. Myriad...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Solynta, disruptor in the potato seed industry, raises €21 million to expand true potato seeds (TPS)

News Commentary | July 30, 2021

Solynta, a Netherlands‑based company, raised €21 million in Series C funding to accelerate the full potential of true potato seeds (TPS). Potatoes are predominantly clonally propagated using tubers. Seeds from the potato berries are called true potato seeds. Solynta's innovative F1 hybrid breeding ... Not part of subscription

Marrone Bio is ready to register new microbial crop protection product in U.S.

News Commentary | September 14, 2021

Marrone Bio Innovations (MBI) is on track to submit its MBI‑306 nematicide/insecticide in the U.S. row and specialty crop markets. It claims that the proprietary microbe, developed from the original Burkholderia rinojensis strain A396, has shown improved results as a broad‑spectrum insect control ... Not part of subscription

Researchers unveil genomic monitoring as a diagnostic tool for managing crop pest resistance

News Commentary | January 10, 2022

Genetically modified crops harboring the genes of Bacillus thuringiensis produce the same bacterial toxin in plant cells, thereby protecting the crops from pests. Over the years, pests have adapted to these toxins and developed resistance, causing crop losses. Researchers at the University of ... Not part of subscription